We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

188 hedge funds and large institutions have $370M invested in SANGAMO THERAPEUTICS INC in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 74 increasing their positions, 46 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

66% more call options, than puts

Call options by funds: $2.56M | Put options by funds: $1.54M

61% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 46

6.98% more ownership

Funds ownership: 54.16% → 61.14% (+7%)

4% less funds holding

Funds holding: 195 → 188 (-7)

14% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 21

19% less capital invested

Capital invested by funds: $458M → $370M (-$87.4M)

Holders
188
Holders Change
-7
Holders Change %
-3.59%
% of All Funds
3.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
74
Reduced
46
Closed
21
Calls
$2.56M
Puts
$1.54M
Net Calls
+$1.02M
Net Calls Change
-$672K

Top Buyers

Rank Fund Capital Flow
1
RCMU
Rokos Capital Management (UK)
United Kingdom
+$8.86M
2
WA
Wasatch Advisors
Utah
+$7.85M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$6.01M
4
CC
Casdin Capital
New York
+$4.32M
5
BlackRock
BlackRock
New York
+$3.25M

Top Sellers

Rank Fund Capital Flow
1
GLA
Great Lakes Advisors
Illinois
-$3.04M
2
Federated Hermes
Federated Hermes
Pennsylvania
-$1.53M
3
PAM
Panagora Asset Management
Massachusetts
-$1.16M
4
UBS Group
UBS Group
Switzerland
-$1.14M
5
CI Investments Inc
CI Investments Inc
Ontario, Canada
-$875K
Name Holding Trade Value Shares
Change 		Change in
Stake
RPAM
26
Rhenman & Partners Asset Management
Sweden
$2.9M -$266K -61,429 -8%
Bank of America
27
Bank of America
North Carolina
$2.89M -$193K -44,664 -6%
Nordea Investment Management
28
Nordea Investment Management
Sweden
$2.74M +$141K +32,682 +5%
Citadel Advisors
29
Citadel Advisors
Florida
$2.58M +$486K +112,295 +22%
Two Sigma Advisers
30
Two Sigma Advisers
New York
$2.42M +$81.7K +18,900 +3%
Mirae Asset Global Investments
31
Mirae Asset Global Investments
South Korea
$2.29M +$732K +169,334 +44%
LFCM
32
Long Focus Capital Management
Puerto Rico
$2.19M +$822K +190,000 +56%
Wells Fargo
33
Wells Fargo
California
$1.97M -$470K -108,601 -19%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$1.91M +$80.9K +18,718 +4%
AllianceBernstein
35
AllianceBernstein
Tennessee
$1.82M +$1.24M +287,616 +189%
CSS
36
Cubist Systematic Strategies
Connecticut
$1.77M +$1.59M +368,151 +623%
Macquarie Group
37
Macquarie Group
Australia
$1.67M – – –
Connor, Clark & Lunn Investment Management (CC&L)
38
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.6M +$1.17M +271,712 +237%
Citigroup
39
Citigroup
New York
$1.44M +$956K +221,118 +176%
William Blair & Company
40
William Blair & Company
Illinois
$1.43M – – –
ECM
41
ExodusPoint Capital Management
New York
$1.3M +$1.36M +313,442 New
GCM
42
Graham Capital Management
Connecticut
$1.29M +$1.35M +311,960 New
Rafferty Asset Management
43
Rafferty Asset Management
New York
$1.28M -$786K -181,645 -37%
Swiss National Bank
44
Swiss National Bank
Switzerland
$1.21M – – –
Ohio Public Employees Retirement System (OPERS)
45
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.18M +$467K +107,963 +61%
Group One Trading
46
Group One Trading
Illinois
$1.04M +$115K +26,634 +12%
Voloridge Investment Management
47
Voloridge Investment Management
Florida
$1.03M -$365K -84,472 -25%
PIM
48
Platinum Investment Management
Australia
$904K – – –
UBS Group
49
UBS Group
Switzerland
$818K -$1.14M -262,764 -57%
Susquehanna International Group
50
Susquehanna International Group
Pennsylvania
$757K -$125K -28,875 -14%
1
2
3 4 5

SGMO Hedge Fund Activity: Q2 2022 in Review

188 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2022, worth a combined $370M — down 19% from $458M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of SGMO and 18 opened new positions — a net loss of 3 holders — while 46 trimmed existing stakes and 74 added.

The largest buyer was Rokos Capital Management (UK), adding an estimated $8.86M. The largest seller was Great Lakes Advisors, exiting entirely with an estimated $3.04M sold.

  • 188 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2022, down from 195 in Q1 2022.
  • Funds reported $370M of SANGAMO THERAPEUTICS INC stock for Q2 2022, down 19% quarter-over-quarter.
  • 18 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2022 and 21 closed out, a net change of -3 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q2 2022 was Rokos Capital Management (UK), an estimated $8.86M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q2 2022 was Great Lakes Advisors, an estimated $3.04M sold.

Based on aggregated 13F filings for Q2 2022.